Resistance to chemotherapeutic drugs in ESCC is observed in the NF-κB pathway, which not only enhances proliferation, angiogenesis, and metastasis, but also contributes to the development of ESCC (34). The gene discussed is NFKB1; the disease is esophageal squamous cell carcinoma.